LT3280721T - Azoto iprito darinių gavimo būdas - Google Patents
Azoto iprito darinių gavimo būdasInfo
- Publication number
- LT3280721T LT3280721T LTEP16722854.3T LT16722854T LT3280721T LT 3280721 T LT3280721 T LT 3280721T LT 16722854 T LT16722854 T LT 16722854T LT 3280721 T LT3280721 T LT 3280721T
- Authority
- LT
- Lithuania
- Prior art keywords
- iprite
- derivatives
- obtaining nitrogen
- nitrogen
- obtaining
- Prior art date
Links
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 title 2
- 229910052757 nitrogen Inorganic materials 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/06—Compounds containing nitro groups bound to a carbon skeleton having nitro groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/14—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/20—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Seasonings (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1507903.1A GB201507903D0 (en) | 2015-05-08 | 2015-05-08 | Process for preparation of nitrogen mustard derivatives |
| PCT/EP2016/060242 WO2016180740A1 (en) | 2015-05-08 | 2016-05-06 | Process for preparation of nitrogen mustard derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3280721T true LT3280721T (lt) | 2020-12-28 |
Family
ID=53489337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP16722854.3T LT3280721T (lt) | 2015-05-08 | 2016-05-06 | Azoto iprito darinių gavimo būdas |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10287316B2 (lt) |
| EP (1) | EP3280721B1 (lt) |
| JP (1) | JP6862354B2 (lt) |
| KR (1) | KR102593509B1 (lt) |
| CN (1) | CN107810189B (lt) |
| AU (1) | AU2016260693B2 (lt) |
| BR (1) | BR112017024051A2 (lt) |
| CA (1) | CA2983559C (lt) |
| CY (1) | CY1123468T1 (lt) |
| ES (1) | ES2826401T3 (lt) |
| GB (1) | GB201507903D0 (lt) |
| HR (1) | HRP20201616T1 (lt) |
| HU (1) | HUE051196T2 (lt) |
| IL (1) | IL255428B (lt) |
| LT (1) | LT3280721T (lt) |
| MX (1) | MX388420B (lt) |
| PL (1) | PL3280721T3 (lt) |
| PT (1) | PT3280721T (lt) |
| RS (1) | RS60952B1 (lt) |
| RU (1) | RU2715233C2 (lt) |
| SI (1) | SI3280721T1 (lt) |
| SM (1) | SMT202000550T1 (lt) |
| WO (1) | WO2016180740A1 (lt) |
| ZA (1) | ZA201707226B (lt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3866931T3 (pl) | 2018-10-18 | 2023-06-19 | Oncopeptides Ab | Związki zawierające deuter |
| JP7475635B2 (ja) * | 2020-01-30 | 2024-04-30 | 公立大学法人大阪 | 含窒素化合物およびその製造方法、ならびに該含窒素化合物を含む光機能性材料 |
| CN112546969B (zh) * | 2020-12-07 | 2022-12-23 | 安徽贝克制药股份有限公司 | 催化加氢连续生产装置和利托那韦中间体的制备方法 |
| EP4347615B1 (en) | 2021-06-01 | 2025-05-21 | Synthon B.V. | Process for making melflufen or a salt thereof |
| GB202204171D0 (en) | 2022-03-24 | 2022-05-11 | Oncopeptides Ab | Novel formulations |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6992207B2 (en) * | 2000-06-13 | 2006-01-31 | Oncopeptides Ab | Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| SE0002202D0 (sv) * | 2000-06-13 | 2000-06-13 | Karolinska Innovations Ab | New peptides |
| JP4982685B2 (ja) * | 2001-12-03 | 2012-07-25 | バイエル、ファーマシューテイカルズ、コーポレイション | ヒトがんを処置するための他の細胞毒剤又は細胞増殖抑制剤と組合わせたアリール尿素化合物 |
| TW200615273A (en) * | 2004-11-10 | 2006-05-16 | Nicholas Piramal India Ltd | Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha |
| US8030328B2 (en) * | 2005-05-20 | 2011-10-04 | Elan Pharmaceuticals, Inc. | Imidazolone phenylalanine derivatives |
| CN100491339C (zh) | 2007-04-20 | 2009-05-27 | 苏州市立德化学有限公司 | 一种抗肿瘤药物美法仑的合成工艺 |
| EP2346836B1 (en) * | 2008-10-08 | 2018-03-07 | Cephalon, Inc. | Processes for the preparation of bendamustine |
| CA3024230C (en) | 2011-04-28 | 2022-10-18 | Oncopeptides Ab | Lyophilized preparation of cytotoxic dipeptides |
| US20130079383A1 (en) * | 2011-07-13 | 2013-03-28 | Arrowhead Research Corporation | Lipid Compounds Targeting VLA-4 |
| WO2014065751A1 (en) | 2012-10-26 | 2014-05-01 | Oncopeptides Ab | Lyophilized preparations of melphalan flufenamide |
| WO2014141294A2 (en) * | 2013-03-11 | 2014-09-18 | Biophore India Pharmaceuticals Pvt. Ltd. | An improved process for the synthesis of melphalan and the hydrochloride salt |
| ITMI20130896A1 (it) * | 2013-05-31 | 2014-12-01 | Farmabios Spa | Processo di purificazione di melphalan |
-
2015
- 2015-05-08 GB GBGB1507903.1A patent/GB201507903D0/en not_active Ceased
-
2016
- 2016-05-06 CN CN201680026550.8A patent/CN107810189B/zh active Active
- 2016-05-06 SM SM20200550T patent/SMT202000550T1/it unknown
- 2016-05-06 JP JP2017558492A patent/JP6862354B2/ja active Active
- 2016-05-06 BR BR112017024051-3A patent/BR112017024051A2/pt active Search and Examination
- 2016-05-06 PL PL16722854T patent/PL3280721T3/pl unknown
- 2016-05-06 LT LTEP16722854.3T patent/LT3280721T/lt unknown
- 2016-05-06 PT PT167228543T patent/PT3280721T/pt unknown
- 2016-05-06 WO PCT/EP2016/060242 patent/WO2016180740A1/en not_active Ceased
- 2016-05-06 CA CA2983559A patent/CA2983559C/en active Active
- 2016-05-06 MX MX2017014292A patent/MX388420B/es unknown
- 2016-05-06 RU RU2017142725A patent/RU2715233C2/ru active
- 2016-05-06 KR KR1020177035258A patent/KR102593509B1/ko active Active
- 2016-05-06 AU AU2016260693A patent/AU2016260693B2/en not_active Ceased
- 2016-05-06 SI SI201630942T patent/SI3280721T1/sl unknown
- 2016-05-06 RS RS20201255A patent/RS60952B1/sr unknown
- 2016-05-06 HR HRP20201616TT patent/HRP20201616T1/hr unknown
- 2016-05-06 US US15/572,300 patent/US10287316B2/en active Active
- 2016-05-06 EP EP16722854.3A patent/EP3280721B1/en active Active
- 2016-05-06 ES ES16722854T patent/ES2826401T3/es active Active
- 2016-05-06 HU HUE16722854A patent/HUE051196T2/hu unknown
-
2017
- 2017-10-24 ZA ZA2017/07226A patent/ZA201707226B/en unknown
- 2017-11-05 IL IL255428A patent/IL255428B/en unknown
-
2020
- 2020-10-13 CY CY20201100964T patent/CY1123468T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3325443T3 (pl) | Sposób otrzymywania pridopidyny | |
| PL3167096T3 (pl) | Dwuetapowy sposób nanoszenia | |
| DK3319956T3 (da) | Substituerede oxopyridinderivater | |
| LT3303334T (lt) | Tirozinkinazės inhibitoriai | |
| MA44474A (fr) | Nouveaux inhibiteurs de la ferroportine | |
| DK3294885T3 (da) | Fremgangsmåde til at fremstille rna | |
| DK3473621T3 (da) | Fremgangsmåde til fremstilling af diphenylmethan-derivat | |
| EP3386505A4 (en) | AZA-BENZIMIDAZOLINHIBITORS OF PAD4 | |
| IL272851A (en) | Methods of using dipivefrin | |
| EP3356447A4 (en) | INHIBITORS OF MENACHINONE BIOSYNTHESIS | |
| PL3457851T3 (pl) | Pochodne sobetiromu | |
| LT3288944T (lt) | Imidazopirazinonai, kaip pde1 inhibitoriai | |
| DK3341379T3 (da) | EZH2-hæmmere | |
| IL253889A0 (en) | Detection of brain injury | |
| DK3283210T3 (da) | Fremgangsmåde | |
| LT3371168T (lt) | Indolin-2-ono dariniai | |
| PL3393468T3 (pl) | Metody leczenia niedoboru odporności | |
| LT3661562T (lt) | Cys-mab konjugavimo būdas | |
| FR3023290B1 (fr) | Derives de flavaglines | |
| PL3630738T3 (pl) | Sposób wytwarzania ozanimodu | |
| DK3346990T3 (da) | Fremgangsmåde til stråleformaling | |
| PT3143018T (pt) | Derivados da caboxamida | |
| IL313083A (en) | Terlipressin compositions and their methods of use | |
| DK3360863T3 (da) | Etomidatderivat og mellemprodukt, fremgangsmåde til fremstilling og anvendelse deraf | |
| KR20180084834A (ko) | 장치 및 그러한 장치의 제조 방법 |